American Heart Journal
Volume 155, Issue 1 , Pages 26.e1-26.e13, January 2008

Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)

  • The ORIGIN Trial Investigators

      Affiliations

    • Corresponding Author InformationReprint requests: Hertzel C. Gerstein, ORIGIN Project Office, Population Health Research Institute, 237 Barton Street East, 2nd Floor, Hamilton, Ontario, Canada L8L 2X2.

Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada

Received 4 July 2007; accepted 21 September 2007. published online 23 November 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 NCT00069784@clinicaltrials.gov.

PII: S0002-8703(07)00772-7

doi:10.1016/j.ahj.2007.09.009

American Heart Journal
Volume 155, Issue 1 , Pages 26.e1-26.e13, January 2008

Article Tools